BioAegis Therapeutics, Inc. will present to investors at the Marcum Microcap Conference on June 15, 2017. This conference is a nationally recognized forum for private and publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. It draws over 2000 participants from the microcap community. BioAegis CEO, Susan Levinson, PhD, will be presenting.
When: Thursday, June 15, 2017, 4 PM
Where: Winter Garden Room, Grand Hyatt New York, New York, NY.